3 documents found, page 1 of 1
Association of Sexualized Drug Use Patterns with HIV/STI Transmission Risk in a...
Guerras, Juan-Miguel; Hoyos Miller, Juan; Agustí, Cristina; Chanos, Sophocles; Pichon, François; Kuske, Matthias; Cigan, Bojan; Fuertes, RicardoWe estimated the prevalence of overall sexualized drug use (SDU) and of chemsex in particular, assessed patterns of drug use, and identified subpopulations of men who have sex with men (MSM) where SDU and chemsex are more frequent. Using data from an online survey of 9407 MSM recruited during 2016 in 7 European countries, we calculated the proportion of participants who reported SDU and chemsex (mephedrone, met...
Insight into antibiotics removal: exploring the photocatalytic performance of a...
Fernández, L.; Gamallo, M.; González-Gómez, M. A.; Vázquez-Vázquez, C.; Rivas, J.; Pintado, M.; Moreira, M. T.The purpose of this research was the preparation and photocatalytic evaluation of a novel nanocomposite (NC) based on Fe3O4/ZnO, to eliminate four persistent antibiotics in surface waters: sulfamethoxazole, trimethoprim, erythromycin and roxithromycin. Prior to the operation of the photocatalytic reactor, the influence of pH (3-9), catalyst concentration (50-800 mg L-1), oxidant dose (0-100 mg L-1) and concentr...
Pre-clinical antigenicity studies of an innovative multivalent vaccine for huma...
Cecílio, P; Pérez-Cabezas, B; Fernández, L.; Moreno, J; Carrillo, E; Requena, J; Fichera, E; Reed, S; Coler, R; Kamhawi, S; Oliveira, F; Valenzuela, JThe notion that previous infection by Leishmania spp. in endemic areas leads to robust anti-Leishmania immunity, supports vaccination as a potentially effective approach to prevent disease development. Nevertheless, to date there is no vaccine available for human leishmaniasis. We optimized and assessed in vivo the safety and immunogenicity of an innovative vaccine candidate against human visceral leishmaniasis...